Adapt Health Corp. AHCO
We take great care to ensure that the data presented and summarized in this overview for AdaptHealth Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AHCO
View all-
Oep Capital Advisors, L.P. New York, NY13.8MShares$118 Million100.0% of portfolio
-
Black Rock Inc. New York, NY13.6MShares$116 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$107 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.71MShares$82.6 Million2.29% of portfolio
-
Sky Knight Capital, L.P.8.58MShares$73 Million93.65% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.01MShares$68.2 Million0.19% of portfolio
-
Reinhart Partners, Inc.7.24MShares$61.6 Million2.98% of portfolio
-
Segall Bryant & Hamill, LLC Chicago, IL4.8MShares$40.9 Million0.65% of portfolio
-
State Street Corp Boston, MA4.47MShares$38 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.38MShares$28.8 Million0.01% of portfolio
Latest Institutional Activity in AHCO
Top Purchases
Top Sells
About AHCO
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Insider Transactions at AHCO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Feb 01
2025
|
Richard W. Rew Ii CLO and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
48,409
+50.0%
|
-
|
|
Feb 01
2025
|
Iii Russell E. Schuster Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99,006
+41.91%
|
-
|
|
Feb 01
2025
|
Toby Scott Barnhart Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,932
+29.24%
|
-
|
|
Feb 01
2025
|
Jason A Clemens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,863
+18.72%
|
-
|
|
Feb 01
2025
|
Albert A. Prast Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,932
+14.23%
|
-
|
|
Feb 01
2025
|
Suzanne Foster Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
271,090
+31.31%
|
-
|
|
Feb 01
2025
|
Christine E. Archbold Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,950
+29.88%
|
-
|
|
Dec 10
2024
|
Jason A Clemens Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
35,000
-7.68%
|
$315,000
$9.35 P/Share
|
|
Nov 13
2024
|
Dale B Wolf Director |
SELL
Open market or private sale
|
Direct |
7,000
-8.55%
|
$70,000
$10.8 P/Share
|
|
Oct 24
2024
|
Diana L Nole Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,699
+50.0%
|
-
|
|
Sep 23
2024
|
Toby Scott Barnhart Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
89,392
+50.0%
|
-
|
|
Sep 20
2024
|
Shaw Rietkerk |
SELL
Open market or private sale
|
Direct |
25,000
-10.52%
|
$275,000
$11.24 P/Share
|
|
Aug 29
2024
|
David Solomon Williams Iii Director |
SELL
Open market or private sale
|
Direct |
4,000
-9.78%
|
$44,000
$11.26 P/Share
|
|
Jun 24
2024
|
Gregory Belinfanti Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,629
+25.61%
|
-
|
|
Jun 24
2024
|
David Solomon Williams Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,629
+25.61%
|
-
|
|
Jun 24
2024
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,101
+23.46%
|
-
|
|
Jun 24
2024
|
Bradley J Coppens Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,523
+23.83%
|
-
|
|
Jun 24
2024
|
Terence J Connors Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,629
+22.15%
|
-
|
|
Jun 24
2024
|
Theodore B. Lundberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,523
+2.07%
|
-
|
|
Jun 24
2024
|
Susan T Weaver Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,629
+17.54%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.25M shares |
|---|
| Open market or private sale | 75.5K shares |
|---|---|
| Payment of exercise price or tax liability | 12.1K shares |
| Other acquisition or disposition | 4.05M shares |